| 1 |
33297669 |
10.3324/haematol.2020.267294 |
2022 |
Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas. |
CD58 |
| 2 |
34560683 |
10.1097/PAS.0000000000001813 |
2022 |
A Comprehensive Clinicopathologic and Molecular Study of 19 Primary Effusion Lymphomas in HIV-infected Patients. |
CD58 |
| 3 |
34727819 |
10.1080/10428194.2021.1992755 |
2022 |
Immunophenotypic expression and immunomodulation in minimal residual disease analysis of pediatric B acute lymphoblastic leukemia by high sensitive flow cytometry. |
CD58 |
| 4 |
35317330 |
10.14740/wjon1436 |
2022 |
Non-GCB Diffuse Large B-Cell Lymphoma With an Atypical Disease Course: A Case Report and Clinical Exome Analysis. |
CD58 |
| 5 |
35491222 |
10.11406/rinketsu.63.313 |
2022 |
[Epigenetic modification as a therapeutic approach for B-cell lymphoma]. |
CD58 |
| 6 |
35622145 |
10.1007/s00428-022-03348-x |
2022 |
CD2-negative lymphoma-associated T-cells: a potential mechanism of immune-evasion in diffuse large B-cell lymphoma. |
CD58 |
| 7 |
35881486 |
10.1172/JCI159402 |
2022 |
Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses. |
CD58 |
| 8 |
33340851 |
10.1016/j.leukres.2020.106491 |
2021 |
Additional flow cytometric studies for differential diagnosis between Burkitt lymphoma/leukemia and B-cell precursor acute lymphoblastic leukemia. |
CD58 |
| 9 |
33479306 |
10.1038/s41598-020-80376-0 |
2021 |
Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma. |
CD58 |
| 10 |
33544565 |
10.1097/PAS.0000000000001658 |
2021 |
Immunophenotypic Spectrum and Genomic Landscape of Refractory Celiac Disease Type II. |
CD58 |
| 11 |
33777778 |
10.3389/fonc.2021.628807 |
2021 |
Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma. |
CD58 |
| 12 |
34168659 |
10.3389/fimmu.2021.705260 |
2021 |
CD58 Immunobiology at a Glance. |
CD58 |
| 13 |
34339834 |
10.1016/j.critrevonc.2021.103430 |
2021 |
Prognostic and therapeutic value of somatic mutations in diffuse large B-cell lymphoma: A systematic review. |
CD58 |
| 14 |
34470052 |
10.1182/bloodadvances.2020003534 |
2021 |
Targeting pediatric leukemia-propagating cells with anti-CD200 antibody therapy. |
CD58 |
| 15 |
34937829 |
10.3960/jslrt.21007 |
2021 |
Tumor microenvironment of adult T-cell leukemia/lymphoma. |
CD58 |
| 16 |
31254446 |
10.1002/cyto.b.21834 |
2020 |
Immunophenotypic Characterization and Purification of Neoplastic Cells from Lymph Nodes Involved by T-Cell/Histiocyte-rich Large B-cell Lymphoma by Flow Cytometry and Flow Cytometric Cell Sorting. |
CD58 |
| 17 |
31962268 |
10.1016/j.molimm.2020.01.006 |
2020 |
EZH2 inhibitors restore epigenetically silenced CD58 expression in B-cell lymphomas. |
CD58 |
| 18 |
32027255 |
10.19746/j.cnki.issn.1009-2137.2020.01.012 |
2020 |
[Analysis of Clinical Characteristics and Therapeutic Efficacy of Patients with Adult Acute Lymphoblastic Leukemia]. |
CD58 |
| 19 |
32068791 |
10.1093/ajcp/aqaa007 |
2020 |
Improved Recognition of Hematogones From Precursor B-Lymphoblastic Leukemia by a Single Tube Flow Cytometric Analysis. |
CD58 |
| 20 |
32281503 |
10.1080/10428194.2020.1742902 |
2020 |
Immunophenotypic modulation in pediatric B lymphoblastic leukemia and its implications in MRD detection. |
CD58 |
| 21 |
32322878 |
10.1093/ibd/izaa065 |
2020 |
Propagation of EBV-driven Lymphomatous Transformation of Peripheral Blood B Cells by Immunomodulators and Biologics Used in the Treatment of Inflammatory Bowel Disease. |
CD58 |
| 22 |
32589698 |
10.1182/blood.2020005546 |
2020 |
Rosetting T cells in Hodgkin lymphoma are activated by immunological synapse components HLA class II and CD58. |
CD58 |
| 23 |
31292115 |
10.1182/blood.2019001126 |
2019 |
Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma. |
CD58 |
| 24 |
31597848 |
10.11406/rinketsu.60.1229 |
2019 |
[The immune microenvironment in malignant lymphoma]. |
CD58 |
| 25 |
31934533 |
10.1155/2019/8586354 |
2019 |
Tumor Microenvironment in Diffuse Large B-Cell Lymphoma: Role and Prognosis. |
CD58 |
| 26 |
28888074 |
10.1002/cyto.b.21591 |
2018 |
Early recovery of circulating immature B cells in B-lymphoblastic leukemia patients after CD19 targeted CAR T cell therapy: A pitfall for minimal residual disease detection. |
CD58 |
| 27 |
29164976 |
10.1080/10428194.2017.1403598 |
2018 |
Ibrutinib and idelalisib block immunophenotypic changes associated with the adhesion and activation of CLL cells in the tumor microenvironment. |
CD58 |
| 28 |
29500862 |
10.1111/ijlh.12795 |
2018 |
Role of CD81 and CD58 in minimal residual disease detection in pediatric B lymphoblastic leukemia. |
CD58 |
| 29 |
29564225 |
10.3389/fonc.2018.00054 |
2018 |
Mechanisms of Immune Evasion and Immune Modulation by Lymphoma Cells. |
CD58 |
| 30 |
29857068 |
10.1016/j.jid.2018.04.038 |
2018 |
Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type. |
CD58 |
| 31 |
29902581 |
10.1016/j.meegid.2018.06.010 |
2018 |
Low responsiveness to a hepatitis B virus vaccine in a Chinese population lacks association with ITGAL, CD58, TNFSF15, CCL15, TGFB3, and BCL6 gene variants. |
CD58 |
| 32 |
29963520 |
10.5045/br.2018.53.2.138 |
2018 |
Leukemia propagating cells in Philadelphia chromosome-positive ALL: a resistant phenotype with an adverse prognosis. |
CD58 |
| 33 |
30093402 |
10.1182/blood-2018-03-838524 |
2018 |
Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with <i>DUSP22</i> rearrangements. |
CD58 |
| 34 |
30113764 |
10.1111/ijlh.12912 |
2018 |
Easy discrimination of hematogones from lymphoblasts in B-cell progenitor acute lymphoblastic leukemia patients using CD81/CD58 expression ratio. |
CD58 |
| 35 |
27998726 |
10.1016/j.ajpath.2016.10.007 |
2017 |
Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. |
CD58 |
| 36 |
28063722 |
10.1016/j.jfma.2016.12.002 |
2017 |
Concordance of two approaches in monitoring of minimal residual disease in B-precursor acute lymphoblastic leukemia: Fusion transcripts and leukemia-associated immunophenotypes. |
CD58 |
| 37 |
28245371 |
10.7534/j.issn.1009-2137.2017.01.005 |
2017 |
[Expression of CD146 in Adult and Children's Acute B Cell Lymphoblastic Leukemia and Its Significance]. |
CD58 |
| 38 |
28324281 |
10.1007/s12185-017-2206-4 |
2017 |
Detection of minimal residual disease in childhood B-acute lymphoblastic leukemia by 4-color flowcytometry. |
CD58 |
| 39 |
28446317 |
10.7534/j.issn.1009-2137.2017.02.051 |
2017 |
[Research Progress on Relationship between CD58 Molecule and ALL and Lymphoma -Review]. |
CD58 |
| 40 |
28627735 |
10.1111/cas.13303 |
2017 |
Genetic alterations in adult T-cell leukemia/lymphoma. |
CD58 |
| 41 |
28694326 |
10.1182/blood-2017-02-768234 |
2017 |
Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E). |
CD58 |
| 42 |
28854975 |
10.1186/s12967-017-1286-5 |
2017 |
Ruxolitinib/nilotinib cotreatment inhibits leukemia-propagating cells in Philadelphia chromosome-positive ALL. |
CD58 |
| 43 |
26930456 |
10.1016/j.leukres.2015.12.015 |
2016 |
CD38+ CD58- is an independent adverse prognostic factor in paediatric Philadelphia chromosome negative B cell acute lymphoblastic leukaemia patients. |
CD58 |
| 44 |
27069035 |
10.1093/labmed/lmw009 |
2016 |
Hematogones With Lambda Light Chain Restriction in a 4-Year-Old Boy With Burkitt Lymphoma: A Potential Diagnostic Pitfall. |
CD58 |
| 45 |
27276707 |
10.18632/oncotarget.9793 |
2016 |
Relapsed diffuse large B-cell lymphoma present different genomic profiles between early and late relapses. |
CD58 |
| 46 |
27383875 |
10.1515/folmed-2016-0004 |
2016 |
Immunophenotypic Modulation of the Blast Cells in Childhood Acute Lymphoblastic Leukemia Minimal Residual Disease Detection. |
CD58 |
| 47 |
27389058 |
10.1038/leu.2016.161 |
2016 |
Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cells. |
CD58 |
| 48 |
27438018 |
10.1097/MPH.0000000000000624 |
2016 |
Key Markers of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia. |
CD58 |
| 49 |
27467287 |
10.1038/gene.2016.30 |
2016 |
CD58 mutations are common in Hodgkin lymphoma cell lines and loss of CD58 expression in tumor cells occurs in Hodgkin lymphoma patients who relapse. |
CD58 |
| 50 |
27825110 |
10.18632/oncotarget.13065 |
2016 |
Mutations or copy number losses of CD58 and TP53 genes in diffuse large B cell lymphoma are independent unfavorable prognostic factors. |
CD58 |
| 51 |
25486581 |
10.1038/bmt.2014.274 |
2015 |
Presence of CD34(+)CD38(-)CD58(-) leukemia-propagating cells at diagnosis identifies patients at high risk of relapse with Ph chromosome-positive ALL after allo-hematopoietic SCT. |
CD58 |
| 52 |
25582824 |
10.1038/mt.2015.4 |
2015 |
Enhancing antitumor efficacy of chimeric antigen receptor T cells through constitutive CD40L expression. |
CD58 |
| 53 |
25800755 |
10.1200/JCO.2014.57.7080 |
2015 |
Diffuse large B-cell lymphoma classification system that associates normal B-cell subset phenotypes with prognosis. |
CD58 |
| 54 |
25991819 |
10.1158/1078-0432.CCR-14-2116 |
2015 |
Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas. |
CD58 |
| 55 |
26106001 |
10.3960/jslrt.55.13 |
2015 |
Mutation Analysis for TP53 in Chronic-Type Adult T-Cell Leukemia/Lymphoma. |
CD58 |
| 56 |
26194173 |
10.1002/gcc.22276 |
2015 |
Alterations of the CD58 gene in classical Hodgkin lymphoma. |
CD58 |
| 57 |
26287347 |
|
2015 |
[Expression of CD58 in childhood B-lineage acute lymphoblastic leukemia and its feasibility in minimal residual disease detection]. |
CD58 |
| 58 |
26550829 |
10.1159/000431058 |
2015 |
Molecular Pathology of Adult T-Cell Leukemia/Lymphoma. |
CD58 |
| 59 |
24413734 |
10.1038/ng.2873 |
2014 |
Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. |
CD58 |
| 60 |
25135692 |
10.1038/leu.2014.228 |
2014 |
CD34(+)CD38(-)CD58(-) cells are leukemia-propagating cells in Philadelphia chromosome-positive acute lymphoblastic leukemia. |
CD58 |
| 61 |
25320005 |
10.1158/0008-5472.CAN-14-0643 |
2014 |
Molecular characterization of chronic-type adult T-cell leukemia/lymphoma. |
CD58 |
| 62 |
22467604 |
10.1002/cyto.b.21017 |
2012 |
Standardizing minimal residual disease by flow cytometry for precursor B lineage acute lymphoblastic leukemia in a developing country. |
CD58 |
| 63 |
22585868 |
10.1158/2159-8290.CD-RW2011-64 |
2012 |
Gene inactivation promotes immune escape in DLBCL. |
CD58 |
| 64 |
22713438 |
10.1177/120347541201600305 |
2012 |
Biologic therapy in psoriasis: perspectives on associated risks and patient management. |
CD58 |
| 65 |
20634374 |
10.1182/blood-2008-01-130252 |
2011 |
Human CD14hi monocytes and myeloid dendritic cells provide a cell contact-dependent costimulatory signal for early CD40 ligand expression. |
CD58 |
| 66 |
21669033 |
10.3727/096368911X580536 |
2011 |
Establishment, characterization, and successful adaptive therapy against human tumors of NKG cell, a new human NK cell line. |
CD58 |
| 67 |
22137796 |
10.1016/j.ccr.2011.11.006 |
2011 |
Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma. |
CD58 |
| 68 |
19854598 |
10.1016/j.anl.2009.08.004 |
2010 |
Maxillofacial mass as the first presentation of acute lymphoblastic leukemia in a nine-year-old girl. |
CD58 |
| 69 |
20886718 |
|
2010 |
[Minimal residual disease monitoring by flow cytometry in children with acute lymphoblastic leukemia]. |
CD58 |
| 70 |
21344762 |
|
2010 |
[Cells antigens' expression modulation during induction treatment of childhood acute lymphoblastic leukemia]. |
CD58 |
| 71 |
19573409 |
|
2009 |
[Application of effective antigen combinations in childhood B lineage acute lymphoblastic leukemia]. |
CD58 |
| 72 |
18412874 |
10.1111/j.1365-4632.2008.03470.x |
2008 |
Combining systemic retinoids with biologic agents for moderate to severe psoriasis. |
CD58 |
| 73 |
18423260 |
10.1016/j.jaad.2008.02.039 |
2008 |
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. |
CD58 |
| 74 |
18489039 |
10.1016/j.jaad.2006.05.074 |
2008 |
Patch-stage mycosis fungoides in remission after therapy with alefacept. |
CD58 |
| 75 |
18809238 |
10.1016/j.exphem.2008.07.003 |
2008 |
Costimulation molecule expression and subset distribution of blood dendritic cells in normal children and newly diagnosed pediatric leukemia and lymphoma patients. |
CD58 |
| 76 |
17349557 |
10.1016/j.sder.2006.12.002 |
2007 |
Complications and adverse reactions in the use of newer biologic agents. |
CD58 |
| 77 |
17365261 |
10.1080/09546630601121045 |
2007 |
Alefacept in corticosteroid refractory graft versus host disease: early results indicate promising activity. |
CD58 |
| 78 |
16928307 |
|
2006 |
[Prognostic significance of lymphocyte function associated anti-gen-3 (CD58) in childhood B cell-acute lymphocytic leukemia]. |
CD58 |
| 79 |
15538405 |
10.1038/sj.leu.2403559 |
2005 |
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection. |
CD58 |
| 80 |
15737916 |
10.1016/j.meegid.2004.08.006 |
2005 |
Cell membrane proteins and quasispecies compartmentalization of CSF and plasma HIV-1 from aids patients with neurological disorders. |
CD58 |
| 81 |
15762287 |
10.1309/x5vv6fkjq6mublpx |
2005 |
CD58 expression decreases as nonmalignant B cells mature in bone marrow and is frequently overexpressed in adult and pediatric precursor B-cell acute lymphoblastic leukemia. |
CD58 |
| 82 |
16021141 |
10.1016/j.jaad.2005.02.043 |
2005 |
Transformed mycosis fungoides developing after treatment with alefacept. |
CD58 |
| 83 |
16247429 |
10.1038/sj.bmt.1705185 |
2005 |
Rapid response to alefacept given to patients with steroid resistant or steroid dependent acute graft-versus-host disease: a preliminary report. |
CD58 |
| 84 |
15360006 |
10.1080/10428190310001643358 |
2004 |
Defective immune function of primary effusion lymphoma cells is associated with distinct KSHV gene expression profiles. |
CD58 |
| 85 |
12393484 |
10.1182/blood-2002-07-1989 |
2003 |
T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect. |
CD58 |
| 86 |
12669246 |
10.1007/s00262-002-0364-5 |
2003 |
Human acute lymphoblastic leukemia (ALL) blasts as accessory cells during T-cell activation: differences between patients in costimulatory capacity affect proliferative responsiveness and cytokine release by activated T cells. |
CD58 |
| 87 |
12671023 |
10.1093/jnci/95.7.548 |
2003 |
Antitumor immunity after vaccination with B lymphoma cells overexpressing a triad of costimulatory molecules. |
CD58 |
| 88 |
12915579 |
10.1128/jvi.77.17.9669-9684.2003 |
2003 |
Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus. |
CD58 |
| 89 |
14594504 |
10.1089/152581603322448187 |
2003 |
CD34+ cells and CD34+CD38- subset from mobilized blood show different patterns of adhesion molecules compared to those from steady-state blood, bone marrow, and cord blood. |
CD58 |
| 90 |
14607753 |
|
2003 |
Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia. |
CD58 |
| 91 |
14689062 |
|
2003 |
Multiparametric flow cytometry in detection of minimal residual disease in acute lymphoblastic leukemia of early B-cell phenotype. |
CD58 |
| 92 |
12008089 |
10.1016/s0145-2126(01)00198-9 |
2002 |
Cutaneous lymphoblastic lymphoma of putative plasmacytoid dendritic cell-precursor origin: two cases. |
CD58 |
| 93 |
12215016 |
10.1007/BF02982580 |
2002 |
Establishment of a primary effusion lymphoma cell line (RM-P1) and in vivo growth system using SCID mice. |
CD58 |
| 94 |
12357356 |
10.1038/sj.leu.2402672 |
2002 |
CD40 ligand-stimulated B cell precursor leukemic cells elicit interferon-gamma production by autologous bone marrow T cells in childhood acute lymphoblastic leukemia. |
CD58 |
| 95 |
11145841 |
10.1006/cyto.2000.0794 |
2001 |
Characterization of cytokine, growth factor receptor, costimulatory and adhesion molecule expression patterns of bone marrow blasts in relapsed childhood B cell precursor all. |
CD58 |
| 96 |
11264179 |
10.1182/blood.v97.7.2115 |
2001 |
Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia. |
CD58 |
| 97 |
11389007 |
10.1182/blood.v97.12.3713 |
2001 |
The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features. |
CD58 |
| 98 |
11426534 |
10.3109/10428190109097660 |
2001 |
Adhesion molecule expression, clinical features and therapy outcome in childhood acute lymphoblastic leukemia. |
CD58 |
| 99 |
10664622 |
10.1309/BFH5-NCNP-DK3J-DQBH |
2000 |
Angiodestruction and tissue necrosis of skin-involving CD56+ NK/T-cell lymphoma are influenced by expression of cell adhesion molecules and cytotoxic granule and apoptosis-related proteins. |
CD58 |
| 100 |
11061342 |
10.3727/000000001108747408 |
2000 |
CD18/CD54(+CD102), CD2/CD58 pathway-independent killing of lymphokine-activated killer (LAK) cells against glioblastoma cell lines T98G and U373MG. |
CD58 |
Datasets
Models
